Envlo

Search results

Bio & Pharma Daewoong Pharm set to export Envlo Tab to Russia, CIS

Daewoong Pharmaceutical, a leading South Korean pharmaceutical company will export its new diabetes drug Envlo Tab. (active ingredient:enavogliflozi...

Dec 01, 2023 (Gmt+09:00)
Bio & Pharma Daewoong applies for approval of Envlo in Saudi Arabia

South Korea's Daewoong Pharmaceutical Co. announced on Friday that it has submitted an application for regulatory approval of its new diabetes treat...

Aug 25, 2023 (Gmt+09:00)
Bio & Pharma Korea's Daewoong to export diabetes drug Envlo to Brazil, Mexico

South Korea’s Daewoong Pharmaceutical Co. said on Feb. 24 it is set to embark on global sales of Envlo, a new drug for diabetes, by exportin...

Feb 24, 2023 (Gmt+09:00)

Cookies on KED Global

We use cookies to provide the best user experience. By continuing to browse this website, you will be considered to accept cookies. Please review our Privacy Policy to learn our cookie policy.

Cookies on KED Global Sites

THE KOREA ECONOMIC DAILY, GLOBAL EDITION

SIGN IN
JOIN

Companies
Korean Investors
- Korean Investors Home
- Best Asset Managers by Korean Investors
Deals
- M&A
- ECM/DCM
Markets
Culture & Trends
Perspectives
Hidden Champions
Future Unicorns

Follow us

Envlo

Cookies on KED Global

No articles were found.Please search again.

No articles were found.
Please search again.